Clinical trial
Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III…
NCT00352300 · Gynecologic Oncology Group, Other · Completed
Key facts
| NCT number | NCT00352300 |
|---|---|
| Title | Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer |
| Official title | A Phase I Trial of Dose Dense (Biweekly) Carboplatin Combined With Paclitaxel and Pegfilgrastim (Neulasta): A Feasibility Study in Patients With Untreated Stage III and IV Ovarian, Tubal or Primary Peritoneal Cancer |
| Lead sponsor | Gynecologic Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Fallopian Tube Carcinoma, Infectious Disorder, Neutropenia, Ovarian Carcinosarcoma, Primary Peritoneal Carcinoma, Stage III Ovarian Cancer, Stage IV Ovarian Cancer |
| Intervention type | Biological, Drug, Procedure |
| Interventions | Adjuvant Therapy, Carboplatin, Paclitaxel, Pegfilgrastim |
| Enrollment | 43 |
| Start date | Jun 1, 2006 |
| Primary completion | Jul 1, 2010 |
| First posted | Jul 14, 2006 |
| Last update posted | Dec 31, 2014 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: